Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kurma Partners is a prominent venture capital firm founded in 2009 and headquartered in Paris, France. With a strong focus on the healthcare and biotechnology sectors, Kurma Partners has established itself as a key player in the European investment landscape. The firm manages approximately €890 million in assets and has successfully financed over 72 companies since its inception. Kurma Partners is distinguished by its commitment to supporting early-stage ventures and its collaborative approach with leading European research centers. This unique positioning allows them to foster innovative medical solutions that address critical healthcare challenges. The firm’s leadership comprises experienced professionals with deep expertise in both investment and the healthcare industry, ensuring that they are well-equipped to identify and nurture promising startups. Kurma Partners is recognized for its strategic investments that not only provide capital but also facilitate valuable partnerships and resources for portfolio companies, enhancing their growth potential and market impact.
Kurma Partners primarily invests in the healthcare and biotechnology sectors, targeting early-stage companies that demonstrate innovative potential. Their investment strategy encompasses a wide range of stages, including pre-seed, seed, seed-plus, Series A, Series B, Series C, and growth equity. This flexibility allows Kurma Partners to engage with startups at various points in their development, from initial creation to capital expansion. The firm actively collaborates with leading European research centers, leveraging their networks and expertise to support the development of groundbreaking medical solutions. Kurma Partners seeks to invest in companies that are not only technologically advanced but also have a clear vision for addressing significant healthcare needs. By focusing on sectors that are critical to improving patient outcomes, Kurma Partners aims to drive innovation and foster sustainable growth within the healthcare ecosystem.
Kurma Partners boasts a diverse portfolio of 72 companies, showcasing its commitment to advancing healthcare and biotechnology innovation. Notable investments include Adcytherix, Altamira Therapeutics, Alveus Therapeutics, Amolyt Pharma, Cardiologs, DNA Script, Ganymed Robotics, ImCheck, Pharvaris, and Xeltis. These companies operate across various domains, including biotechnology, health technology, and diagnostics, reflecting Kurma Partners' broad investment scope within the healthcare sector. The firm’s strategic investments have not only contributed to the growth of these companies but have also positioned them to make significant impacts in their respective fields. By supporting a range of innovative solutions, Kurma Partners plays a vital role in shaping the future of healthcare and enhancing patient care through technology and research.
To pitch Kurma Partners, founders should email their proposals to contact@kurmapartners.com. It is recommended to include a detailed overview of the business, market potential, and how the startup aligns with Kurma's focus on healthcare and biotechnology. Warm introductions may be beneficial, but cold applications are also accepted.
Kurma Partners invests across a wide range of stages, including pre-seed, seed, seed-plus, Series A, Series B, Series C, and growth equity. This diverse approach allows them to engage with companies at various points in their development, providing the necessary support for growth and expansion.
Founders interested in pitching to Kurma Partners can reach out via email at contact@kurmapartners.com. It is advisable to provide a clear overview of the business model, market potential, and how the company aligns with Kurma's focus on healthcare and biotechnology.
Kurma Partners primarily focuses on the healthcare and biotechnology sectors. They are particularly interested in early-stage companies that are developing innovative solutions to address significant healthcare challenges.
While specific check sizes are not detailed, Kurma Partners invests across various stages, which typically implies a range of investment amounts tailored to the needs of the companies they support.
Kurma Partners focuses its investments within Europe, particularly in countries that are home to leading research centers and innovative healthcare companies.
Interested founders should prepare a comprehensive pitch that outlines their business model, market opportunity, and alignment with Kurma's investment focus. They can submit their pitch via email to contact@kurmapartners.com.
Kurma Partners offers strategic support to its portfolio companies, leveraging its extensive network within European research centers to facilitate collaborations and enhance growth opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.